These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen? Ioannou GN, Kowdley KV. Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663 [No Abstract] [Full Text] [Related]
3. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Natarajan Y, Patel P, Chu J, Yu X, Hernaez R, El-Serag H, Kanwal F. Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703 [Abstract] [Full Text] [Related]
4. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P. J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668 [Abstract] [Full Text] [Related]
7. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358 [Abstract] [Full Text] [Related]
9. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population. Ezzikouri S, El Feydi AE, El Kihal L, Afifi R, Benazzouz M, Hassar M, Chafik A, Pineau P, Benjelloun S. Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971 [Abstract] [Full Text] [Related]
10. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D. J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300 [Abstract] [Full Text] [Related]
13. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Holmström P, Marmur J, Eggertsen G, Gåfvels M, Stål P. Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814 [Abstract] [Full Text] [Related]
15. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, Bovo G, Boari G, Mancia G. Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249 [Abstract] [Full Text] [Related]
16. Screening for iron overload in the Turkish population. Barut G, Balci H, Bozdayi M, Hatemi I, Ozcelik D, Senturk H. Dig Dis; 2003 Oct; 21(3):279-85. PubMed ID: 14571105 [Abstract] [Full Text] [Related]
17. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Lauret E, Rodríguez M, González S, Linares A, López-Vázquez A, Martínez-Borra J, Rodrigo L, López-Larrea C. Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382 [Abstract] [Full Text] [Related]